Literature DB >> 26835161

Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review.

David M Marks1, Amy Newhouse2.   

Abstract

Fibromyalgia is a painful disorder with no curative treatments, and available medications typically provide partial relief of pain. Reported here is the effective use of serial intravenous lidocaine infusions for the chronic management of 3 patients with fibromyalgia. The details of the infusion procedure are described, and relevant literature is reviewed. Lidocaine infusions should be considered in fibromyalgia patients who are refractory to other treatments, and a positive response to 1 infusion may justify repeated infusions for chronic management.

Entities:  

Year:  2015        PMID: 26835161      PMCID: PMC4732305          DOI: 10.4088/PCC.15br01804

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  12 in total

1.  Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

Authors:  J H Raphael; J L Southall; G D Kitas
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

2.  Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis.

Authors:  Eveline Nüesch; Winfried Häuser; Kathrin Bernardy; Jürgen Barth; Peter Jüni
Journal:  Ann Rheum Dis       Date:  2012-06-27       Impact factor: 19.103

3.  Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia.

Authors:  Roberto Vlainich; Adriana Machado Issy; Rioko Kimiko Sakata
Journal:  Clin J Pain       Date:  2011-05       Impact factor: 3.442

4.  Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics.

Authors:  Istvan Nagy; Clifford J Woolf
Journal:  Pain       Date:  1996-01       Impact factor: 6.961

Review 5.  Systemic administration of local anesthetic agents to relieve neuropathic pain.

Authors:  V Challapalli; I W Tremont-Lukats; E D McNicol; J Lau; D B Carr
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury.

Authors:  B S Galer; K V Miller; M C Rowbotham
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

7.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02

8.  The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord.

Authors:  Clifford J Woolf; Zsuzsanna Wiesenfeld-Hallin
Journal:  Pain       Date:  1985-12       Impact factor: 6.961

9.  Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

Authors:  J Sörensen; A Bengtsson; E Bäckman; K G Henriksson; M Bengtsson
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

10.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04
View more
  3 in total

1.  Evaluation of the effects of neural therapy in patients diagnosed with fibromyalgia.

Authors:  Turgay Altınbilek; Rabia Terzi; Aynur Başaran; Sena Tolu; Seher Küçüksaraç
Journal:  Turk J Phys Med Rehabil       Date:  2019-01-23

Review 2.  Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain.

Authors:  Janell Tully; Jai Won Jung; Anjana Patel; Alyson Tukan; Sameer Kandula; Allen Doan; Farnad Imani; Giustino Varrassi; Elyse M Cornett; Alan David Kaye; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-01-02

3.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.